Stock comparison
Grifols
LeMaitre Vascular
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
GRFS
Grifols
Market cap
$6.75B
Sector
Healthcare
LMAT
LeMaitre Vascular
Market cap
$2.23B
Sector
Healthcare
Overall winner
LeMaitre Vascular LMAT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | GRFS | LMAT | Winner |
|---|---|---|---|
| Warren Buffett | 59D | 77B | LMAT |
| Benjamin Graham | 54C | 89A | LMAT |
| Philip Fisher | 50C | 81C | LMAT |
| Peter Lynch | 44D | 67B | LMAT |
| Joel Greenblatt | 26F | 56D | LMAT |
| Charlie Munger | 44D | 68D | LMAT |
| Terry Smith | 47D | 69D | LMAT |
Side-by-side metrics
| Metric | GRFS | LMAT |
|---|---|---|
| Market cap | $6.75B | $2.23B |
| P/E (TTM) | 14.9x | 37.1x |
| EV/EBIT | 12.8x | 36.6x |
| ROIC (TTM) | 5.49% | 9.43% |
| Gross margin | 37.68% | 72.39% |
| Net margin | 5.58% | 24.35% |
| Revenue CAGR 5y | 10.02% | 12.75% |
| EPS CAGR 5y | 20.54% | 19.04% |
| Debt / Equity | 1.8x | 0.5x |
| Dividend yield | 1.65% | 0.84% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
GRFS leads on
- Market cap$6.75Bvs $2.23B+67%
- EV/EBIT12.8xvs 36.6x+65%
- P/E (TTM)14.9xvs 37.1x+60%
- Dividend yield1.65%vs 0.84%+49%
LMAT leads on
- Net margin24.35%vs 5.58%+77%
- Debt / Equity0.5xvs 1.8x+74%
- Gross margin72.39%vs 37.68%+48%
- ROIC (TTM)9.43%vs 5.49%+42%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.